These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 14597147

  • 1. Anterior hypothalamic beta-adrenergic activity in the maintenance of hypertension in aortic coarctated rats.
    Höcht C, Opezzo JA, Taira CA.
    Pharmacol Res; 2004 Jan; 49(1):17-21. PubMed ID: 14597147
    [Abstract] [Full Text] [Related]

  • 2. Anterior hypothalamic beta-adrenoceptors in chronic aortic-coarctated hypertensive rats: an interaction with central angiotensin II receptors.
    Höcht C, Opezzo JA, Gironacci MM, Peña C, Taira CA.
    Clin Exp Pharmacol Physiol; 2005 Jan; 32(1-2):30-4. PubMed ID: 15730431
    [Abstract] [Full Text] [Related]

  • 3. Study of the hypothalamic angiotensin system in aortic coarctated rats using the reverse microdialysis technique.
    Höcht C, Opezzo JA, Gironacci M, Peña C, Taira CA.
    Pharmacol Res; 2003 Sep; 48(3):301-7. PubMed ID: 12860451
    [Abstract] [Full Text] [Related]

  • 4. Hypothalamic antihypertensive effect of metoprolol in chronic aortic coarctated rats.
    Höcht C, Opezzo JA, Taira CA.
    Clin Exp Pharmacol Physiol; 2005 Aug; 32(8):681-6. PubMed ID: 16120197
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic-pharmacodynamic properties of metoprolol in chronic aortic coarctated rats.
    Höcht C, Di Verniero C, Opezzo JA, Taira CA.
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):1-8. PubMed ID: 15300360
    [Abstract] [Full Text] [Related]

  • 6. Hypothalamic antihypertensive effect of irbesartan in chronic aortic coarctated rats.
    Höcht C, Opezzo JA, Taira CA.
    Pharmacology; 2005 Mar; 73(3):146-54. PubMed ID: 15564789
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and the cardiovascular effects of irbesartan in aortic coarctated rats.
    Höcht C, Opezzo JA, Taira CA.
    Pharmacology; 2004 Jan; 70(1):23-30. PubMed ID: 14646353
    [Abstract] [Full Text] [Related]

  • 8. In vivo and in vitro pharmacodynamic properties of metoprolol in aortic coarctated rats.
    Höcht C, Di Verniero C, Opezzo JA, Taira CA.
    Pharmacol Res; 2003 Mar; 47(3):181-8. PubMed ID: 12591012
    [Abstract] [Full Text] [Related]

  • 9. Applicability of microdialysis as a technique for pharmacokinetic-pharmacodynamic (PK-PD) modeling of antihypertensive beta-blockers.
    Höcht C, DiVerniero C, Opezzo JA, Taira CA.
    J Pharmacol Toxicol Methods; 2005 Mar; 52(2):244-50. PubMed ID: 16125622
    [Abstract] [Full Text] [Related]

  • 10. Further evidence of the inhibitory role of perifornical hypothalamic beta-adrenergic receptors in the feeding behaviour of hungry rats.
    Bendotti C, Villa M, Samanin R.
    Life Sci; 1986 Jan 20; 38(3):259-66. PubMed ID: 2867451
    [Abstract] [Full Text] [Related]

  • 11. Beta adrenergic receptors facilitate norepinephrine release from rat hypothalamic and hippocampal slices.
    Murugaiah KD, O'Donnell JM.
    Res Commun Mol Pathol Pharmacol; 1995 Nov 20; 90(2):179-90. PubMed ID: 8747788
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic and pharmacodynamic alterations of methyldopa in rats with aortic coarctation. A study using microdialysis.
    Höcht C, Opezzo JA, Gorzalczany SB, Priano RM, Bramuglia GF, Taira CA.
    Pharmacol Res; 2001 Nov 20; 44(5):377-83. PubMed ID: 11712868
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
    Whalen EJ, Bates JN, Johnson AK, Lewis SJ.
    Br J Pharmacol; 2006 Apr 20; 147(7):755-64. PubMed ID: 16474417
    [Abstract] [Full Text] [Related]

  • 14. beta-adrenoreceptor blocking and antihypertensive activity of PP-24, a newly synthesized aryloxypropanolamine derivative.
    Nikam AP, Bodhankar SL, Piplani P, Bansal J, Thakurdesai PA.
    J Pharm Pharmacol; 2008 Nov 20; 60(11):1501-6. PubMed ID: 18957171
    [Abstract] [Full Text] [Related]

  • 15. Interaction between beta 2- and alpha 2-adrenoceptor responses in the vascular system: effect of clenbuterol.
    Kazanietz MG, Gutkind JS, Enero MA.
    Eur J Pharmacol; 1986 Oct 14; 130(1-2):119-24. PubMed ID: 3023111
    [Abstract] [Full Text] [Related]

  • 16. Failure of isoprenaline and beta-receptor blocking drugs to modify depressor response and bradycardia induced by electrical stimulation of the anterior hypothalamus of cats.
    Iijima T, Philippu A.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 May 14; 312(1):27-30. PubMed ID: 6104794
    [Abstract] [Full Text] [Related]

  • 17. In vivo evidence that isoproterenol may increase heart rate in the rat by mechanisms in addition to activation of cardiac beta(1)- or beta(2)-adrenoceptors.
    Whalen EJ, Lewis SJ.
    Eur J Pharmacol; 1999 Oct 15; 382(3):207-10. PubMed ID: 10556671
    [Abstract] [Full Text] [Related]

  • 18. Further evidence of interaction between vasodilator beta 2- and vasoconstrictor alpha 2-adrenoceptor-mediated responses in maintaining vascular tone in anesthetized rats.
    Kazanietz MG, Gutkind JS, Puyo A, Armando I, Enero MA.
    J Cardiovasc Pharmacol; 1989 Dec 15; 14(6):874-80. PubMed ID: 2481776
    [Abstract] [Full Text] [Related]

  • 19. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE, Cavero I, Manoury P, Lefevre-Borg F, Langer SZ.
    J Pharmacol Exp Ther; 1987 Sep 15; 242(3):1025-34. PubMed ID: 2888869
    [Abstract] [Full Text] [Related]

  • 20. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM, Wu BN, Ho WC, Hong SJ, Chen SJ, Lin YT, Chen IJ.
    Pharmacology; 1997 Apr 15; 54(4):211-24. PubMed ID: 9211567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.